Last $2.44 USD
Change Today +0.01 / 0.41%
Volume 4.2M
CTIC On Other Exchanges
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Louis A. Bianco CPA

Co-Founder, Principal Financial Officer, Principal Accounting Officer, Chief Governance Officer, Executive Vice President of Finance & Administration and Secretary, CTI BioPharma Corp.
AgeTotal Calculated CompensationThis person is connected to 120 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Louis A. Bianco, CPA is a Co- Founder of Cell Therapeutics, Inc. and has been its Executive Vice President of Finance and Administration since February 1, 1992. Mr. Bianco serves as Principal Accounting Officer, Principal Financial Officer and Secretary of Cell Therapeutics and has been its Chief Governance Officersince September 2013. From January 1989 to January 1992, he served as a Vice President at Deutsche Bank Capital Corporation in charge of risk management. ...

Read Full Background

Corporate Headquarters*

3101 Western Avenue
Seattle, Washington 98121

United States

Phone: 206-282-7100
Fax: 206-284-6206

Board Members Memberships*

There is no Board Members Memberships data available.


New York University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$553,500

Stock Options*

Restricted Stock Awards$493,158
All Other Compensation$44,886
Exercisable Options100,428
Exercisable Options Value$14,000
Unexercisable Options100,000
Unexercisable Options Value$14,000
Total Value of Options$28,000
Total Number of Options200,428

Total Compensation*

Total Annual Cash Compensation$598,386
Total Short Term Compensation$553,500
Other Long Term Compensation$538,044
Total Calculated Compensation$1,376,484
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CTIC:US $2.44 USD +0.01


Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
Rick Gonzalez Chief Executive Officer
Navidea Biopharmaceuticals, Inc
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Werner Lanthaler MBA,MPAChief Executive Officer
Evotec AG
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CTI BIOPHARMA CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at